Chest Cancer Molecular Diagnostics Market - Global Outlook and Forecast 2021-2027

April 2021 | 106 pages | ID: C29F256B9503EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Chest Cancer Molecular Diagnostics in Global, including the following market information:

Global Chest Cancer Molecular Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Chest Cancer Molecular Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chest Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chest Cancer Molecular Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Chest Cancer Molecular Diagnostics Market Segment Percentages, By Type, 2020 (%)

• PCR
• FISH
• DNA Sequencing
• Gene Chip

China Chest Cancer Molecular Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Chest Cancer Molecular Diagnostics Market Segment Percentages, By Application, 2020 (%)

• Clinical Diagnosis
• Drug Screening
• Research

Global Chest Cancer Molecular Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Chest Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Chest Cancer Molecular Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Chest Cancer Molecular Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Roche
• Qiagen
• Illumina
• Abbott
• Oncotypeiq
• BD
• Tellgen
• Genetech
• Gpmedical
• Zeesan
• Sansure

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chest Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chest Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHEST CANCER MOLECULAR DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Chest Cancer Molecular Diagnostics Market Size: 2021 VS 2027
2.2 Global Chest Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chest Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Chest Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Chest Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Chest Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Chest Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chest Cancer Molecular Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Chest Cancer Molecular Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chest Cancer Molecular Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Chest Cancer Molecular Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 PCR
  4.1.3 FISH
  4.1.4 DNA Sequencing
  4.1.5 Gene Chip
4.2 By Type - Global Chest Cancer Molecular Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Chest Cancer Molecular Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global Chest Cancer Molecular Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chest Cancer Molecular Diagnostics Market Size, 2021 & 2027
  5.1.2 Clinical Diagnosis
  5.1.3 Drug Screening
  5.1.4 Research
5.2 By Application - Global Chest Cancer Molecular Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Chest Cancer Molecular Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global Chest Cancer Molecular Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Chest Cancer Molecular Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Chest Cancer Molecular Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Chest Cancer Molecular Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global Chest Cancer Molecular Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Chest Cancer Molecular Diagnostics Revenue, 2016-2027
  6.3.2 US Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.3.3 Canada Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.3.4 Mexico Chest Cancer Molecular Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Chest Cancer Molecular Diagnostics Revenue, 2016-2027
  6.4.2 Germany Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.3 France Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.4 U.K. Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.5 Italy Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.6 Russia Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.8 Benelux Chest Cancer Molecular Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Chest Cancer Molecular Diagnostics Revenue, 2016-2027
  6.5.2 China Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.3 Japan Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.4 South Korea Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.6 India Chest Cancer Molecular Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Chest Cancer Molecular Diagnostics Revenue, 2016-2027
  6.6.2 Brazil Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.6.3 Argentina Chest Cancer Molecular Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue, 2016-2027
  6.7.2 Turkey Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.3 Israel Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia Chest Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.5 UAE Chest Cancer Molecular Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Chest Cancer Molecular Diagnostics Major Product Offerings
  7.1.4 Roche Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Qiagen
  7.2.1 Qiagen Corporate Summary
  7.2.2 Qiagen Business Overview
  7.2.3 Qiagen Chest Cancer Molecular Diagnostics Major Product Offerings
  7.2.4 Qiagen Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.2.5 Qiagen Key News
7.3 Illumina
  7.3.1 Illumina Corporate Summary
  7.3.2 Illumina Business Overview
  7.3.3 Illumina Chest Cancer Molecular Diagnostics Major Product Offerings
  7.3.4 Illumina Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.3.5 Illumina Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott Chest Cancer Molecular Diagnostics Major Product Offerings
  7.4.4 Abbott Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.4.5 Abbott Key News
7.5 Oncotypeiq
  7.5.1 Oncotypeiq Corporate Summary
  7.5.2 Oncotypeiq Business Overview
  7.5.3 Oncotypeiq Chest Cancer Molecular Diagnostics Major Product Offerings
  7.5.4 Oncotypeiq Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.5.5 Oncotypeiq Key News
7.6 BD
  7.6.1 BD Corporate Summary
  7.6.2 BD Business Overview
  7.6.3 BD Chest Cancer Molecular Diagnostics Major Product Offerings
  7.6.4 BD Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.6.5 BD Key News
7.7 Tellgen
  7.7.1 Tellgen Corporate Summary
  7.7.2 Tellgen Business Overview
  7.7.3 Tellgen Chest Cancer Molecular Diagnostics Major Product Offerings
  7.4.4 Tellgen Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.7.5 Tellgen Key News
7.8 Genetech
  7.8.1 Genetech Corporate Summary
  7.8.2 Genetech Business Overview
  7.8.3 Genetech Chest Cancer Molecular Diagnostics Major Product Offerings
  7.8.4 Genetech Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.8.5 Genetech Key News
7.9 Gpmedical
  7.9.1 Gpmedical Corporate Summary
  7.9.2 Gpmedical Business Overview
  7.9.3 Gpmedical Chest Cancer Molecular Diagnostics Major Product Offerings
  7.9.4 Gpmedical Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.9.5 Gpmedical Key News
7.10 Zeesan
  7.10.1 Zeesan Corporate Summary
  7.10.2 Zeesan Business Overview
  7.10.3 Zeesan Chest Cancer Molecular Diagnostics Major Product Offerings
  7.10.4 Zeesan Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.10.5 Zeesan Key News
7.11 Sansure
  7.11.1 Sansure Corporate Summary
  7.11.2 Sansure Business Overview
  7.11.3 Sansure Chest Cancer Molecular Diagnostics Major Product Offerings
  7.11.4 Sansure Chest Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.11.5 Sansure Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chest Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Chest Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Chest Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Chest Cancer Molecular Diagnostics in Global Market
Table 5. Top Chest Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Chest Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Chest Cancer Molecular Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Chest Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Chest Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chest Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Chest Cancer Molecular Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Chest Cancer Molecular Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Chest Cancer Molecular Diagnostics Product Offerings
Table 32. Roche Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Qiagen Corporate Summary
Table 34. Qiagen Chest Cancer Molecular Diagnostics Product Offerings
Table 35. Qiagen Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Illumina Corporate Summary
Table 37. Illumina Chest Cancer Molecular Diagnostics Product Offerings
Table 38. Illumina Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. Abbott Corporate Summary
Table 40. Abbott Chest Cancer Molecular Diagnostics Product Offerings
Table 41. Abbott Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Oncotypeiq Corporate Summary
Table 43. Oncotypeiq Chest Cancer Molecular Diagnostics Product Offerings
Table 44. Oncotypeiq Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. BD Corporate Summary
Table 46. BD Chest Cancer Molecular Diagnostics Product Offerings
Table 47. BD Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. Tellgen Corporate Summary
Table 49. Tellgen Chest Cancer Molecular Diagnostics Product Offerings
Table 50. Tellgen Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. Genetech Corporate Summary
Table 52. Genetech Chest Cancer Molecular Diagnostics Product Offerings
Table 53. Genetech Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. Gpmedical Corporate Summary
Table 55. Gpmedical Chest Cancer Molecular Diagnostics Product Offerings
Table 56. Gpmedical Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. Zeesan Corporate Summary
Table 58. Zeesan Chest Cancer Molecular Diagnostics Product Offerings
Table 59. Zeesan Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 60. Sansure Corporate Summary
Table 61. Sansure Chest Cancer Molecular Diagnostics Product Offerings
Table 62. Sansure Chest Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Chest Cancer Molecular Diagnostics Segment by Type
Figure 2. Chest Cancer Molecular Diagnostics Segment by Application
Figure 3. Global Chest Cancer Molecular Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Chest Cancer Molecular Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Chest Cancer Molecular Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chest Cancer Molecular Diagnostics Revenue in 2020
Figure 8. By Type - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Qiagen Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Illumina Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Abbott Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Oncotypeiq Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. BD Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Tellgen Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Genetech Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Gpmedical Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Zeesan Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)